Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study

NCT00274937 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00274937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
February 20, 2006
Completion date
September 30, 2022
Enrollment
111 (actual)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

stage i nasopharyngeal keratinizing squamous cell carcinoma ajcc v7, stage i nasopharyngeal undifferentiated carcinoma ajcc v7, stage ii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7, stage ii nasopharyngeal undifferentiated carcinoma ajcc v7, stage iii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7, stage iii nasopharyngeal undifferentiated carcinoma ajcc v7, stage iv nasopharyngeal keratinizing squamous cell carcinoma ajcc v7, stage iv nasopharyngeal undifferentiated carcinoma ajcc v7